Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1999
09/01/1999EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
09/01/1999EP0938554A1 Human protein kinase c inhibitor homolog
09/01/1999EP0938547A1 Modified ligands of calcium-dependent binding proteins
09/01/1999EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
09/01/1999EP0938494A1 Inhibitors of protein farnesyl transferase
09/01/1999EP0938489A1 New phosphonates, process for preparing the same and medicaments
09/01/1999EP0938487A2 2$i(R),4$i(S),$i(R),$i(S)- AND 2$i(S),4$i(R),$i(R),$i(S)-HYDROXYITRACONAZOLE- AND HYDROXYSAPERCONAZOLE DERIVATIVES
09/01/1999EP0938486A1 Substituted pyrrolopyrimidines and processes for their preparation
09/01/1999EP0938485A1 Benzoxazole derivative with an affinity to binding sites of amino acid receptors
09/01/1999EP0938484A1 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole
09/01/1999EP0938483A2 Muscarinic antagonists
09/01/1999EP0938482A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor
09/01/1999EP0938480A1 Substituted tetrahydro-1,3,5-triazin-2 1h]-thiones as anti-atherosclerotic agents
09/01/1999EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
09/01/1999EP0938476A1 Process for substituted pyridines
09/01/1999EP0938475A1 Piperidine compounds
09/01/1999EP0938474A2 Cyclopropylindole compounds and their use as prodrugs
09/01/1999EP0938472A2 15-fluoro prostaglandins as ocular hypotensives
09/01/1999EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
09/01/1999EP0938345A1 Aqueous-based pharmaceutical composition
09/01/1999EP0938343A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors
09/01/1999EP0938339A1 Formulations for topical use
09/01/1999EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof
09/01/1999EP0938327A1 Method of inhibiting the release of bioactive il-1
09/01/1999EP0938326A1 Synthetic phosphopeptides for treating bone diseases
09/01/1999EP0938325A1 Methods for sterilizing male mammals
09/01/1999EP0938323A2 Treatment of highly vascular tumours
09/01/1999EP0938322A2 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients
09/01/1999EP0938321A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
09/01/1999EP0938320A1 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
09/01/1999EP0938319A1 Pharmaceutical compositions containing alendronate and an agent promoting gastric emptying
09/01/1999EP0938318A1 Tablet with controlled release of alfuzosine chlorydrate
09/01/1999EP0938317A1 Compositions and methods for reducing respiratory depression
09/01/1999EP0938316A2 Galenic composition containing opioid antagonists
09/01/1999EP0938315A1 Immune response modifier compounds for treatment of th2 mediated and related diseases
09/01/1999EP0938314A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (r)-trihexyphenidyl
09/01/1999EP0938313A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-clidinium
09/01/1999EP0938312A1 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
09/01/1999EP0938311A2 Use of efaroxan for producing medicine for treating huntington disease
09/01/1999EP0938310A1 Anti-viral compounds
09/01/1999EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor
09/01/1999EP0938308A1 Antiparasitic agents
09/01/1999EP0938306A1 ANTIMALARIAL COMPOSITIONS CONTAINING $i(CIS)-FUSED CYCLOPENTENO-1,2,4-TRIOXANE DERIVATIVES
09/01/1999EP0938305A2 Method of alleviating pain by means of combining tramadol with an nmda antagonist
09/01/1999EP0938304A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants
09/01/1999EP0938303A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/01/1999EP0938302A1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
09/01/1999EP0938297A1 Immunomodulatory formulation
09/01/1999EP0938296A1 Method of treating alopecia
09/01/1999EP0938258A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no)
09/01/1999EP0886645B1 New 19-nor-pregnene derivatives
09/01/1999EP0835254B1 Oxazolidinone derivatives, their preparation and therapeutical use
09/01/1999EP0828497B1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives
09/01/1999EP0808111B1 A low phosphorus animal feed containing 1 -alpha- hydroxylated vitamin d compounds
09/01/1999EP0764174B1 Process for removing bile salts from a patient and alkylated compositions therefor
09/01/1999EP0721348B1 Monoglyceride/lactate ester permeation enhancer
09/01/1999EP0691842B1 Lidocaine aerosol anaesthetic
09/01/1999EP0687267B1 Pyrrolo-pyridine derivatives as ligands of dopamine receptor
09/01/1999EP0650475B1 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides, their preparation and their use as 5-ht2 antagonists
09/01/1999EP0643780B2 Multiple solvent cleaning system
09/01/1999EP0622078B1 Cholesterol level depressant
09/01/1999EP0573545B1 Monoclonal antibodies against receptor-induced binding sites
09/01/1999CN1227610A Antibodies against a complex of CD4 and a chemokine receptor domain, and their use against HIV infections
09/01/1999CN1227602A Tumor antigen proteins, genes thereof and tumor antigen peptides
09/01/1999CN1227565A Viral peptides with structural homology to protein G of respiratory syncytial virus
09/01/1999CN1227564A Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
09/01/1999CN1227563A Modified oligosaccharides
09/01/1999CN1227560A Thienopyrimidines
09/01/1999CN1227559A Highly lipophilic camptothecin derivatives
09/01/1999CN1227554A Substituted 6,5-hetero-bicyclic derivatives
09/01/1999CN1227553A Bicyclic pyrimidine derivatives and their use as anti-coagulants
09/01/1999CN1227552A Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
09/01/1999CN1227550A Troponyl piperazines as selective dopamine D4 receptor ligands
09/01/1999CN1227547A Arylalkanoyl pyridazines
09/01/1999CN1227544A Tetrahydroquinoline derivatives as EAA antagonists
09/01/1999CN1227543A Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators
09/01/1999CN1227542A N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
09/01/1999CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
09/01/1999CN1227538A Pharmaceutical composition containing 4-oxo-butynic acid
09/01/1999CN1227503A Novel device for transdermal administering of trimegestone
09/01/1999CN1227495A Compositions of plant carbohydrates as dietary supplements
09/01/1999CN1227493A The use of heparin or heparan sulfate in combination with chitosan for prevention or treatment of infections caused by herpes virus
09/01/1999CN1227492A Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine
09/01/1999CN1227491A Method for treating sinusitis with uridine triphosphates and related compounds
09/01/1999CN1227490A Fat emulsion containing xanthine derivative
09/01/1999CN1227489A Adenosine deaminase inhibitors
09/01/1999CN1227488A Improved method for preparing potassim clavulanate
09/01/1999CN1227487A Pharmaceutical compositions containing mesembrine and related compounds
09/01/1999CN1227486A Pharmaceutical compositions comprising S-(-)-N-propargyl-1-amino indan
09/01/1999CN1227485A Treatment of hemoglobinopathy
09/01/1999CN1227483A Anti-caries oral compositions
09/01/1999CN1227482A Cosmetic compositions
09/01/1999CN1227466A Substituted cyclopentane compounds useful as neuraminidase inhibitors
09/01/1999CN1227227A Antisense nucleoside for inhibiting the growth of human malignant tumor
09/01/1999CN1227225A Thiazole derivatives
09/01/1999CN1227101A Medicine synergist
09/01/1999CN1227100A Compound preparation for curing and preventing thrombosis and apoplexy and its preparing method
09/01/1999CN1227099A Novel treatment agent
09/01/1999CN1044912C Thio-substituted cyclic phosphonate compounds, and its pharmaceutical compositions and use
09/01/1999CN1044911C Method for preparing prodrug